LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 41

Search options

  1. Article: Intra-articular delivery of full-length antibodies through the use of an in situ forming depot

    Fayd'herbe De Maudave, Alexis / Leconet, Wilhem / Toupet, Karine / Constantinides, Michael / Bossis, Guillaume / de Toledo, Marion / Vialaret, Jérôme / Hirtz, Christophe / Lopez-Noriega, Adolfo / Jorgensen, Christian / Noël, Daniele / Louis-Plence, Pascale / Grizot, Sylvestre / Villalba, Martin

    Journal of controlled release. 2022 Jan., v. 341

    2022  

    Abstract: Monoclonal antibodies (mAbs) are large size molecules that have demonstrated high therapeutic potential for the treatment of cancer or autoimmune diseases. Despite some excellent results, their intravenous administration results in high plasma ... ...

    Abstract Monoclonal antibodies (mAbs) are large size molecules that have demonstrated high therapeutic potential for the treatment of cancer or autoimmune diseases. Despite some excellent results, their intravenous administration results in high plasma concentration. This triggers off-target effects and sometimes poor targeted tissue distribution. To circumvent this issue, we investigated a local controlled-delivery approach using an in situ forming depot technology. Two clinically relevant mAbs, rituximab (RTX) and daratumumab (DARA), were formulated using an injectable technology based on biodegradable PEG-PLA copolymers. The stability and controlled release features of the formulations were investigated. HPLC and mass spectrometry revealed the preservation of the protein structure. In vitro binding of formulated antibodies to their target antigens and to their cellular FcγRIIIa natural killer cell receptor was fully maintained. Furthermore, encapsulated RTX was as efficient as classical intravenous RTX treatment to inhibit the in vivo tumor growth of malignant human B cells in immunodeficient NSG mice. Finally, the intra-articular administration of the formulated mAbs yielded a sustained local release associated with a lower plasma concentration compared to the intra-articular delivery of non-encapsulated mAbs. Our results demonstrate that the utilization of this polymeric technology is a reliable alternative for the local delivery of fully functional clinically relevant mAbs.
    Keywords biodegradability ; composite polymers ; humans ; intravenous injection ; mass spectrometry ; natural killer cells ; neoplasms ; protein structure ; tissue distribution
    Language English
    Dates of publication 2022-01
    Size p. 578-590.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 632533-6
    ISSN 1873-4995 ; 0168-3659
    ISSN (online) 1873-4995
    ISSN 0168-3659
    DOI 10.1016/j.jconrel.2021.12.010
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: Arthritis sensory and motor scale: predicting functional deficits from the clinical score in collagen-induced arthritis.

    Mausset-Bonnefont, Anne-Laure / Cren, Maïlys / Vicente, Rita / Quentin, Julie / Jorgensen, Christian / Apparailly, Florence / Louis-Plence, Pascale

    Arthritis research & therapy

    2019  Volume 21, Issue 1, Page(s) 264

    Abstract: Background: In the collagen-induced arthritis (CIA) mouse model, inflammation readouts are usually quantified using operator-dependent clinical scoring systems, and no systematic relationship with functional deficits has been detected. In this study, we ...

    Abstract Background: In the collagen-induced arthritis (CIA) mouse model, inflammation readouts are usually quantified using operator-dependent clinical scoring systems, and no systematic relationship with functional deficits has been detected. In this study, we extensively quantified sensory and motor deficits in CIA mice during natural disease progression and therapeutic treatment. Then, we used these data to build a scale to predict functional deficits on the basis of the classical clinical score.
    Methods: Using the CIA mouse model, we longitudinally screened multiple approaches to assess locomotion (open field test, Catwalk™), sensitivity (Von Frey, Hargreaves, static weight-bearing tests), and inflammation (skin temperature), and identified the most accurate tests to correlate sensory and motor deficits with disease severity, measured by clinical score. We then used these tests to characterize functional deficits in control (naïve and mice injected with complete Freund's adjuvant) and CIA mice, either untreated or treated with methotrexate to prevent functional deficits. By mathematical approaches, we finally investigated the relationship between functional deficits and clinical score.
    Results: We found that the functional disability scores obtained with the open field, Catwalk™, Hargreaves, and skin temperature tests significantly correlated with the clinical score in CIA mice, either untreated or treated with methotrexate. Mathematical correlation showed that motor deficits, robustly characterized by two different tests, were twice more responsive than thermal sensitivity deficits.
    Conclusion: We propose the arthritis sensory and motor (ArthriSM) scale as a new theranostic tool to predict motor and sensory deficit based on the clinical score, in the experimental mouse model of CIA. This ArthriSM scale may facilitate the transfer of knowledge between preclinical and clinical studies.
    MeSH term(s) Animals ; Antirheumatic Agents/pharmacology ; Arthritis, Experimental/complications ; Arthritis, Rheumatoid/complications ; Inflammation/etiology ; Locomotion/physiology ; Male ; Methotrexate/pharmacology ; Mice ; Pain/etiology ; Skin Temperature
    Chemical Substances Antirheumatic Agents ; Methotrexate (YL5FZ2Y5U1)
    Language English
    Publishing date 2019-12-04
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2107602-9
    ISSN 1478-6362 ; 1478-6354
    ISSN (online) 1478-6362
    ISSN 1478-6354
    DOI 10.1186/s13075-019-2047-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cellular senescence impact on immune cell fate and function.

    Vicente, Rita / Mausset-Bonnefont, Anne-Laure / Jorgensen, Christian / Louis-Plence, Pascale / Brondello, Jean-Marc

    Aging cell

    2016  Volume 15, Issue 3, Page(s) 400–406

    Abstract: Cellular senescence occurs not only in cultured fibroblasts, but also in undifferentiated and specialized cells from various tissues of all ages, in vitro and in vivo. Here, we review recent findings on the role of cellular senescence in immune cell fate ...

    Abstract Cellular senescence occurs not only in cultured fibroblasts, but also in undifferentiated and specialized cells from various tissues of all ages, in vitro and in vivo. Here, we review recent findings on the role of cellular senescence in immune cell fate decisions in macrophage polarization, natural killer cell phenotype, and following T-lymphocyte activation. We also introduce the involvement of the onset of cellular senescence in some immune responses including T-helper lymphocyte-dependent tissue homeostatic functions and T-regulatory cell-dependent suppressive mechanisms. Altogether, these data propose that cellular senescence plays a wide-reaching role as a homeostatic orchestrator.
    MeSH term(s) Cell Lineage ; Cellular Senescence ; Homeostasis/immunology ; Humans ; Immunity ; Lymphocytes/cytology
    Language English
    Publishing date 2016-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2113083-8
    ISSN 1474-9726 ; 1474-9718
    ISSN (online) 1474-9726
    ISSN 1474-9718
    DOI 10.1111/acel.12455
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Differential Accumulation and Activation of Monocyte and Dendritic Cell Subsets in Inflamed Synovial Fluid Discriminates Between Juvenile Idiopathic Arthritis and Septic Arthritis.

    Cren, Maïlys / Nziza, Nadège / Carbasse, Aurélia / Mahe, Perrine / Dufourcq-Lopez, Emilie / Delpont, Marion / Chevassus, Hugues / Khalil, Mirna / Mura, Thibault / Duroux-Richard, Isabelle / Apparailly, Florence / Jeziorski, Eric / Louis-Plence, Pascale

    Frontiers in immunology

    2020  Volume 11, Page(s) 1716

    Abstract: Despite their distinct etiology, several lines of evidence suggest that innate immunity plays a pivotal role in both juvenile idiopathic arthritis (JIA) and septic arthritis (SA) pathophysiology. Indeed, monocytes and dendritic cells (DC) are involved in ...

    Abstract Despite their distinct etiology, several lines of evidence suggest that innate immunity plays a pivotal role in both juvenile idiopathic arthritis (JIA) and septic arthritis (SA) pathophysiology. Indeed, monocytes and dendritic cells (DC) are involved in the first line of defense against pathogens and play a critical role in initiating and orchestrating the immune response. The aim of this study was to compare the number and phenotype of monocytes and DCs in peripheral blood (PB) and synovial fluid (SF) from patients with JIA and SA to identify specific cell subsets and activation markers associated with pathophysiological mechanisms and that could be used as biomarkers to discriminate both diseases. The proportion of intermediate and non-classical monocytes in the SF and PB, respectively, were significantly higher in JIA than in SA patients. In contrast the proportion of classical monocytes and their absolute numbers were higher in the SF from SA compared with JIA patients. Higher expression of CD64 on non-classical monocyte was observed in PB from SA compared with JIA patients. In SF, higher expression of CD64 on classical and intermediate monocyte as well as higher CD163 expression on intermediate monocytes was observed in SA compared with JIA patients. Moreover, whereas the number of conventional (cDC), plasmacytoid (pDC) and inflammatory (infDC) DCs was comparable between groups in PB, the number of CD141
    MeSH term(s) Adolescent ; Arthritis, Infectious/immunology ; Arthritis, Juvenile/immunology ; Biomarkers/analysis ; Child ; Child, Preschool ; Dendritic Cells/immunology ; Female ; Humans ; Immunophenotyping ; Infant ; Male ; Monocytes/immunology ; Synovial Fluid/immunology
    Chemical Substances Biomarkers
    Language English
    Publishing date 2020-07-31
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2020.01716
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Intra-articular delivery of full-length antibodies through the use of an in situ forming depot.

    Fayd'herbe De Maudave, Alexis / Leconet, Wilhem / Toupet, Karine / Constantinides, Michael / Bossis, Guillaume / de Toledo, Marion / Vialaret, Jérôme / Hirtz, Christophe / Lopez-Noriega, Adolfo / Jorgensen, Christian / Noël, Daniele / Louis-Plence, Pascale / Grizot, Sylvestre / Villalba, Martin

    Journal of controlled release : official journal of the Controlled Release Society

    2021  Volume 341, Page(s) 578–590

    Abstract: Monoclonal antibodies (mAbs) are large size molecules that have demonstrated high therapeutic potential for the treatment of cancer or autoimmune diseases. Despite some excellent results, their intravenous administration results in high plasma ... ...

    Abstract Monoclonal antibodies (mAbs) are large size molecules that have demonstrated high therapeutic potential for the treatment of cancer or autoimmune diseases. Despite some excellent results, their intravenous administration results in high plasma concentration. This triggers off-target effects and sometimes poor targeted tissue distribution. To circumvent this issue, we investigated a local controlled-delivery approach using an in situ forming depot technology. Two clinically relevant mAbs, rituximab (RTX) and daratumumab (DARA), were formulated using an injectable technology based on biodegradable PEG-PLA copolymers. The stability and controlled release features of the formulations were investigated. HPLC and mass spectrometry revealed the preservation of the protein structure. In vitro binding of formulated antibodies to their target antigens and to their cellular FcγRIIIa natural killer cell receptor was fully maintained. Furthermore, encapsulated RTX was as efficient as classical intravenous RTX treatment to inhibit the in vivo tumor growth of malignant human B cells in immunodeficient NSG mice. Finally, the intra-articular administration of the formulated mAbs yielded a sustained local release associated with a lower plasma concentration compared to the intra-articular delivery of non-encapsulated mAbs. Our results demonstrate that the utilization of this polymeric technology is a reliable alternative for the local delivery of fully functional clinically relevant mAbs.
    MeSH term(s) Animals ; Delayed-Action Preparations/chemistry ; Mice ; Polymers/chemistry
    Chemical Substances Delayed-Action Preparations ; Polymers
    Language English
    Publishing date 2021-12-13
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632533-6
    ISSN 1873-4995 ; 0168-3659
    ISSN (online) 1873-4995
    ISSN 0168-3659
    DOI 10.1016/j.jconrel.2021.12.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Nonclassical CD4+CD49b+ Regulatory T Cells as a Better Alternative to Conventional CD4+CD25+ T Cells To Dampen Arthritis Severity.

    Vicente, Rita / Quentin, Julie / Mausset-Bonnefont, Anne-Laure / Chuchana, Paul / Martire, Delphine / Cren, Maïlys / Jorgensen, Christian / Louis-Plence, Pascale

    Journal of immunology (Baltimore, Md. : 1950)

    2016  Volume 196, Issue 1, Page(s) 298–309

    Abstract: Promising immunotherapeutic strategies are emerging to restore tolerance in autoimmune diseases by triggering an increase in the number and/or the function of endogenous regulatory T (Treg) cells, which actively control pathological immune responses. ... ...

    Abstract Promising immunotherapeutic strategies are emerging to restore tolerance in autoimmune diseases by triggering an increase in the number and/or the function of endogenous regulatory T (Treg) cells, which actively control pathological immune responses. Evidence suggests a remarkable heterogeneity in peripheral Treg cells that warrants their better characterization in terms of phenotype and suppressive function, to determine which subset may be optimally suitable for a given clinical situation. We found that repetitive injections of immature dendritic cells expanded Foxp3-negative CD49b(+) Treg cells that displayed an effector memory phenotype. These expanded Treg cells were isolated ex vivo for transcriptome analysis and found to contain multiple transcripts of the canonical Treg signature shared mainly by CD25(+) but also by other subphenotypes. We characterized the CD49b(+) Treg cell phenotype, underscoring its similarities with the CD25(+) Treg cell phenotype and highlighting some differential expression patterns for several markers, including lymphocyte activation gene 3, KLRG1, CD103, ICOS, CTLA-4, and granzyme B. Comparison of the CD25(+) and CD49b(+) Treg cells' suppressive mechanisms, in vitro and in vivo, revealed the latter's potent suppressive activity, which was partly dependent on IL-10 secretion. Altogether, our results strongly suggest that expression of several canonical Treg cell markers and suppressive function could be Foxp3 independent, and underscore the therapeutic potential of IL-10-secreting CD49b(+) Treg cells in arthritis.
    MeSH term(s) Adoptive Transfer ; Animals ; Antigens, CD/metabolism ; Arthritis/immunology ; Arthritis/therapy ; CD4 Antigens/metabolism ; CTLA-4 Antigen/metabolism ; Dendritic Cells/immunology ; Dendritic Cells/transplantation ; Gene Expression Profiling ; Granzymes/metabolism ; Immunologic Memory/immunology ; Immunotherapy/methods ; Inducible T-Cell Co-Stimulator Protein/metabolism ; Integrin alpha Chains/metabolism ; Integrin alpha2/metabolism ; Interleukin-10/secretion ; Interleukin-2 Receptor alpha Subunit/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Inbred DBA ; Mice, Knockout ; Receptors, Immunologic/metabolism ; T-Lymphocytes, Regulatory/immunology ; T-Lymphocytes, Regulatory/transplantation
    Chemical Substances Antigens, CD ; CD223 antigen ; CD4 Antigens ; CTLA-4 Antigen ; IL10 protein, mouse ; Icos protein, mouse ; Inducible T-Cell Co-Stimulator Protein ; Integrin alpha Chains ; Integrin alpha2 ; Interleukin-2 Receptor alpha Subunit ; Klrg1 protein, mouse ; Receptors, Immunologic ; alpha E integrins ; Interleukin-10 (130068-27-8) ; Granzymes (EC 3.4.21.-)
    Language English
    Publishing date 2016-01-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.1501069
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells.

    Pers, Yves-Marie / Quentin, Julie / Feirreira, Rosanna / Espinoza, Francisco / Abdellaoui, Naoill / Erkilic, Nejla / Cren, Maïlys / Dufourcq-Lopez, Emilie / Pullig, Oliver / Nöth, Ulrich / Jorgensen, Christian / Louis-Plence, Pascale

    Theranostics

    2018  Volume 8, Issue 20, Page(s) 5519–5528

    Abstract: Rationale: ...

    Abstract Rationale:
    MeSH term(s) Adipose Tissue/cytology ; Flow Cytometry ; Humans ; Knee Joint/cytology ; Knee Joint/immunology ; Mesenchymal Stem Cells/cytology ; Osteoarthritis, Knee/immunology ; Osteoarthritis, Knee/therapy ; Prospective Studies ; Stromal Cells/cytology
    Language English
    Publishing date 2018-11-05
    Publishing country Australia
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592097-2
    ISSN 1838-7640 ; 1838-7640
    ISSN (online) 1838-7640
    ISSN 1838-7640
    DOI 10.7150/thno.27674
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8+ T Cell Peripheral Tolerance in Irradiated Mice.

    Espinosa-Carrasco, Gabriel / Villard, Marine / Le Saout, Cecile / Louis-Plence, Pascale / Vicente, Rita / Hernandez, Javier

    PloS one

    2015  Volume 10, Issue 6, Page(s) e0130041

    Abstract: Lymphodepletion is currently used to enhance the efficacy of cytotoxic T lymphocyte adoptive transfer immunotherapy against cancer. This beneficial effect of conditioning regimens is due, at least in part, to promoting the breakdown of peripheral CD8+ T ... ...

    Abstract Lymphodepletion is currently used to enhance the efficacy of cytotoxic T lymphocyte adoptive transfer immunotherapy against cancer. This beneficial effect of conditioning regimens is due, at least in part, to promoting the breakdown of peripheral CD8+ T cell tolerance. Lymphodepletion by total body irradiation induces systemic translocation of commensal bacteria LPS from the gastrointestinal tract. Since LPS is a potent activator of the innate immune system, including antigen presenting dendritic cells, we hypothesized that LPS translocation could be required for the breakdown of peripheral tolerance observed in irradiated mice. To address this issue, we have treated irradiated mice with antibiotics in order to prevent LPS translocation and utilized them in T cell adoptive transfer experiments. Surprisingly, we found that despite of completely blocking LPS translocation into the bloodstream, antibiotic treatment did not prevent the breakdown of peripheral tolerance. Although irradiation induced the activation of cross-presenting CD8+ dendritic cells in the lymphoid tissue, LPS could not solely account for this effect. Activation of dendritic cells by mechanisms other than LPS translocation is sufficient to promote the differentiation of potentially autoreactive CD8+ T cells into effectors in irradiated mice. Our data indicate that LPS translocation is dispensable for the breakdown of CD8+ T cell tolerance in irradiated mice.
    MeSH term(s) Animals ; Anti-Bacterial Agents/pharmacology ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Cross-Priming ; Dendritic Cells/drug effects ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Flow Cytometry ; Immune Tolerance/drug effects ; Immune Tolerance/immunology ; Lipopolysaccharides/pharmacology ; Mice ; Mice, Inbred BALB C ; Mice, Transgenic ; Peripheral Tolerance/immunology ; T-Lymphocytes, Cytotoxic/drug effects ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Cytotoxic/metabolism
    Chemical Substances Anti-Bacterial Agents ; Lipopolysaccharides
    Language English
    Publishing date 2015-06-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0130041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Polyoxidonium

    Alexia, Catherine / Cren, Mailys / Louis-Plence, Pascale / Vo, Dang-Nghiem / El Ahmadi, Yasamine / Dufourcq-Lopez, Emilie / Lu, Zhao-Yang / Hernandez, Javier / Shamilov, Farkhad / Chernysheva, Olga / Vasilieva, M / Vorotnikov, I / Vishnevskay, Yana / Tupitsyn, Nikolay / Rossi, Jean-François / Villalba, Martin

    Frontiers in immunology

    2019  Volume 10, Page(s) 2693

    Abstract: Immunotherapy, which is seen as a major tool for cancer treatment, requires, in some cases, the presence of several agents to maximize its effects. Adjuvants can enhance the effect of other agents. However, despite their long-time use, only a few ... ...

    Abstract Immunotherapy, which is seen as a major tool for cancer treatment, requires, in some cases, the presence of several agents to maximize its effects. Adjuvants can enhance the effect of other agents. However, despite their long-time use, only a few adjuvants are licensed today, and their use in cancer treatment is rare. Azoximer bromide, marketed under the trade name Polyoxidonium® (PO), is a copolymer of N-oxidized 1,4-ethylenepiperazine and (N-carboxyethyl)-1,4-ethylene piperazinium bromide. It has been described as an immune adjuvant and immunomodulator that is clinically used with excellent tolerance. PO is used in the treatment and prophylaxis of diseases connected with damage to the immune system, and there is interest in testing it in antitumor therapy. We show here that PO treatment for 1 week induced positive pathological changes in 6 out of 20 patients with breast cancer, including complete response in a triple-negative patient. This correlated with an increased tumor CD4
    MeSH term(s) Adenocarcinoma/drug therapy ; Adenocarcinoma/immunology ; Adjuvants, Immunologic/therapeutic use ; Adult ; Aged ; Breast Neoplasms/drug therapy ; Breast Neoplasms/immunology ; Cell Differentiation/drug effects ; Cell Differentiation/immunology ; Chemotherapy, Adjuvant/methods ; Dendritic Cells/drug effects ; Dendritic Cells/immunology ; Female ; Humans ; Killer Cells, Natural/drug effects ; Killer Cells, Natural/immunology ; Lymphocyte Activation/drug effects ; Lymphocyte Activation/immunology ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Middle Aged ; Neoadjuvant Therapy/methods ; Piperazines/therapeutic use ; Polymers/therapeutic use ; T-Lymphocytes, Cytotoxic/drug effects ; T-Lymphocytes, Cytotoxic/immunology
    Chemical Substances Adjuvants, Immunologic ; Piperazines ; Polymers ; Polyoxidonium
    Language English
    Publishing date 2019-11-28
    Publishing country Switzerland
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2019.02693
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Inducible Treg cell populations as cell based-therapy for rheumatoid arthritis

    Martire Delphine / Quentin Julie / Mausset-Bonnefont Anne-Laure / Asnagli Hélène / Belmonte Nathalie / Foussat Arnaud / Jorgensen Christian / Louis-Plence Pascale

    Journal of Translational Medicine, Vol 10, Iss Suppl 3, p P

    2012  Volume 55

    Keywords Medicine ; R
    Language English
    Publishing date 2012-11-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top